Olestra and the FDA
- PMID: 8692242
- DOI: 10.1056/NEJM199608293350913
Olestra and the FDA
Comment on
-
Olestra and the FDA.N Engl J Med. 1996 Apr 11;334(15):984-6. doi: 10.1056/NEJM199604113341511. N Engl J Med. 1996. PMID: 8596603 No abstract available.
Similar articles
-
Olestra and the FDA.N Engl J Med. 1996 Aug 29;335(9):669-70; author reply 670. N Engl J Med. 1996. PMID: 8692245 No abstract available.
-
Olestra and the FDA.N Engl J Med. 1996 Aug 29;335(9):669; author reply 670. N Engl J Med. 1996. PMID: 8692244 No abstract available.
-
Olestra and the FDA.N Engl J Med. 1996 Apr 11;334(15):984-6. doi: 10.1056/NEJM199604113341511. N Engl J Med. 1996. PMID: 8596603 No abstract available.
-
The selling of olestra.Public Health Rep. 1998 Nov-Dec;113(6):508-20. Public Health Rep. 1998. PMID: 9847922 Free PMC article. Review.
-
Olestra: assessing its potential to interact with drugs in the gastrointestinal tract.Clin Pharmacol Ther. 1997 Jun;61(6):613-8. doi: 10.1016/S0009-9236(97)90094-1. Clin Pharmacol Ther. 1997. PMID: 9209243 Review. No abstract available.
Cited by
-
Authors' financial relationships with the food and beverage industry and their published positions on the fat substitute olestra.Am J Public Health. 2003 Apr;93(4):664-9. doi: 10.2105/ajph.93.4.664. Am J Public Health. 2003. PMID: 12660215 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources